ANAGEN THERAPEUTICS Trademark
Trademark Overview
On Friday, February 8, 2002, a trademark application was filed for ANAGEN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ANAGEN THERAPEUTICS trademark a serial number of 76368275. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, May 7, 2004. This trademark is owned by Anagen Therapeutics, Inc.. The ANAGEN THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations in the nature of pharmaceuticals and nutriceuticals based on epigallocatechin gallate (EGCG) or derivatives thereof for use in treating prostate and skin diseases and for use in nutricutical wellness products; and pharmaceutical preparations based on compounds shown to interact with certain orphan nuclear receptors for use in treating or preventing cardiovascular, neurodegenerative and/or inflammatory diseases
Pharmaceutical research and drug development
General Information
| Serial Number | 76368275 |
| Word Mark | ANAGEN THERAPEUTICS |
| Filing Date | Friday, February 8, 2002 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, May 7, 2004 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations in the nature of pharmaceuticals and nutriceuticals based on epigallocatechin gallate (EGCG) or derivatives thereof for use in treating prostate and skin diseases and for use in nutricutical wellness products; and pharmaceutical preparations based on compounds shown to interact with certain orphan nuclear receptors for use in treating or preventing cardiovascular, neurodegenerative and/or inflammatory diseases |
| Goods and Services | Pharmaceutical research and drug development |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 20, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 20, 2002 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Anagen Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Northbrook, IL 60062 |
Trademark Events
| Event Date | Event Description |
| Friday, May 7, 2004 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, October 14, 2003 | FINAL REFUSAL MAILED |
| Monday, July 21, 2003 | CASE FILE IN TICRS |
| Wednesday, January 22, 2003 | LETTER OF SUSPENSION MAILED |
| Tuesday, December 10, 2002 | ASSIGNED TO EXAMINER |
| Friday, November 1, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 1, 2002 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 3, 2002 | NON-FINAL ACTION MAILED |
| Thursday, May 2, 2002 | ASSIGNED TO EXAMINER |
